DOSAGE UNIT COMPRISING A PROSTAGLANDIN ANALOG FOR TREATING CONSTIPATION
First Claim
Patent Images
1. A dosage unit comprising a prostaglandin (PG) analog represented by Formula (I) and/or its tautomers, and a pharmaceutically suitable excipient, wherein the dosage unit contains said PG analog in the range of about 6-96 μ
- g;
5 Assignments
0 Petitions
Accused Products
Abstract
A dosage unit for treating constipation in a human patient is described. The dosage unit of the invention includes a halogenated prostaglandin analog and a pharmaceutically suitable excipient. The dosage unit relieves constipation without substantial side effects.
-
Citations
17 Claims
- 1. A dosage unit comprising a prostaglandin (PG) analog represented by Formula (I) and/or its tautomers, and a pharmaceutically suitable excipient, wherein the dosage unit contains said PG analog in the range of about 6-96 μ
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeSucampo AG (Mallinckrodt plc)
-
Original AssigneeSucampo AG (Mallinckrodt plc)
-
InventorsUENO, Ryuji, PATCHEN, Myra L.
-
Granted Patent
-
Time in Patent OfficeDays
-
Field of Search
-
US Class Current514/456
-
CPC Class CodesA61K 31/557 Eicosanoids, e.g. leukotrie...A61P 1/00 Drugs for disorders of the ...A61P 1/10 LaxativesA61P 1/14 Prodigestives, e.g. acids, ...A61P 43/00 Drugs for specific purposes...C07C 53/23 containing ringsC07D 311/94 condensed with rings other ...
